| Mature T-Cell and NK-Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived129 of 129show fewer |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 64 trials (19 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 42 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 41 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 35 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 32 trials (13 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 29 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 27 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 26 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 22 trials (7 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 17 trials (9 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 16 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CHOP Regimen 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tofacitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlormethinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daromun 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Mature T-Cell and NK-Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |